MSV
PFE icon

MN Services Vermogensbeheer’s Pfizer PFE Stock Holding History

MN Services Vermogensbeheer’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.9M Sell
1,657,411
-536,600
-24% -$14M 0.3% 67
2026
Q1 		$61.6M Sell
2,194,011
-2,600
-0.1% -$69.2K 0.41% 49
2025
Q4 		$54.7M Buy
2,196,611
+37,611
+2% +$948K 0.34% 63
2025
Q3 		$55M Buy
2,159,000
+38,800
+2% +$958K 0.36% 61
2025
Q2 		$51.4M Buy
2,120,200
+51,900
+3% +$1.21M 0.36% 60
2025
Q1 		$52.4M Sell
2,068,300
-162,000
-7% -$4.24M 0.41% 52
2024
Q4 		$59.2M Buy
2,230,300
+46,200
+2% +$1.25M 0.4% 50
2024
Q3 		$63.2M Sell
2,184,100
-47,800
-2% -$1.39M 0.44% 48
2024
Q2 		$62.4M Sell
2,231,900
-50,900
-2% -$1.4M 0.45% 44
2024
Q1 		$63.3M Sell
2,282,800
-385,500
-14% -$10.7M 0.46% 45
2023
Q4 		$76.8M Sell
2,668,300
-85,800
-3% -$2.59M 0.69% 33
2023
Q3 		$91.4M Buy
2,754,100
+57,400
+2% +$2.03M 0.88% 24
2023
Q2 		$98.9M Buy
+2,696,700
New +$105M 0.92% 22
2019
Q3 		– Sell
-1,002,761
Closed -$41.2M – 542
2019
Q2 		$41.2M Sell
1,002,761
-44,900
-4% -$1.78M 0.48% 45
2019
Q1 		$42.2M Sell
1,047,661
-4,849
-0.5% -$194K 0.49% 49
2018
Q4 		$38.1M Buy
1,052,510
+63,240
+6% +$2.63M 0.58% 42
2018
Q3 		$41.4M Sell
989,270
-8,748
-0.9% -$337K 0.97% 13
2018
Q2 		$34.4M Buy
998,018
+9,908
+1% +$339K 0.86% 19
2018
Q1 		$33.3M Buy
988,110
+9,486
+1% +$326K 0.87% 18
2017
Q4 		$28M Sell
978,624
-58,708
-6% -$2M 0.88% 19
2017
Q3 		$35.1M Buy
1,037,332
+12,715
+1% +$409K 0.92% 16
2017
Q2 		$32.7M Buy
1,024,617
+853,670
+499% +$26.9M 0.9% 16
2017
Q1 		$5.19M Buy
170,947
+4,740
+3% +$149K 1% 15
2016
Q4 		$4.86M Buy
166,207
+837
+0.5% +$25.6K 0.99% 18
2016
Q3 		$5.31M Buy
165,370
+218
+0.1% +$7.29K 1.06% 15
2016
Q2 		$4.97M Buy
165,152
+2,057
+1% +$65.7K 1.15% 13
2016
Q1 		$4.03M Buy
+163,095
New +$4.66M 0.94% 16

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MN Services Vermogensbeheer's PFE Position: Q2 2026 in Review

MN Services Vermogensbeheer reduced its Pfizer (PFE) stake by 24% in Q2 2026, selling an estimated $14M and leaving 1,657,411 shares worth $39.9M. The position accounts for 0.3% of the portfolio, ranked #67.

MN Services Vermogensbeheer first reported a position in PFE in Q1 2016 and has held it in 27 quarters since. The position peaked at $98.9M in Q2 2023. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • MN Services Vermogensbeheer held 1,657,411 shares of Pfizer worth $39.9M as of Q2 2026.
  • MN Services Vermogensbeheer sold 536,600 Pfizer shares in Q2 2026, an estimated $14M.
  • Pfizer made up 0.3% of MN Services Vermogensbeheer's portfolio in Q2 2026, its #67 holding.
  • MN Services Vermogensbeheer first reported a position in Pfizer in Q1 2016 and has held it in 27 quarters since.
  • MN Services Vermogensbeheer's Pfizer position peaked at $98.9M in Q2 2023.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on MN Services Vermogensbeheer's 13F filing for Q2 2026, filed 31 Jul 2026.